Prasad Suyash (CIK 0001679129)

Latest company ownership

Role: CMO and Head of R&D
Shares held
530,589
Last filed at
Jul 7, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jul 5, 2022 Jul 7, 2022 Taysha Gene Therapies, Inc. CMO and Head of R&D Sell 45.0 -12,861 -2.37% $47.6K
Jun 29, 2022 Jul 1, 2022 Taysha Gene Therapies, Inc. CMO and Head of R&D Sell 28.8 -50,139 -8.45% $183.1K
Jun 29, 2021 Jul 1, 2021 Taysha Gene Therapies, Inc. CMO and Head of R&D Sell 20.0 -79,000 -11.75% $1.8M